Ignite Creation Date:
2024-05-06 @ 6:46 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05776446
Status:
COMPLETED
Last Update Posted:
2023-03-20
First Post:
2023-02-13
Brief Title:
Clinical Behavior of the Asqelio Trifocal Diffractive Intraocular Lens
Sponsor:
AST Products Inc
Organization:
AST Products Inc
Study Overview
Official Title:
Retrospective Study on the Clinical Behavior of the Asqelio Trifocal Diffractive Intraocular Lens With Follow-up at 3 Months
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main objective of this study was to evaluate distance intermediate and near vision in patients who have undergone cataract extraction with bilateral implantation of a new hydrophobic trifocal diffractive intraocular lens IOL with a biospheric design the Asqelio Trifocal IOL AST Products Inc Billerica MA USA along with patient-reported outcomes PRO For that purpose the clinical information of 50 eyes from 25 patients was retrospectively analyzed 3 months after implantation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None